Which treatment options should be used in adolescents with polycystic ovary syndrome?

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue 5, 2004, Pages 705-710

  Villa, P ^b   Di Sebastiano, F ^b   Rossodivita, A ^b   Sagnella, F ^b   Barini, A ^b   Fulghesu, A M ^c   Lanzone, Antonio ^a,b  

^a OASI RESEARCH INSTITUTE IRCCS   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Adolescence; Anti androgen; Estroprogestin; Insulin sensitizing drugs; Polycystic ovary syndrome; Progestin; Treatment

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; DEXAMETHASONE; ESTROGEN; FINASTERIDE; FLUTAMIDE; GESTAGEN; GONADORELIN AGONIST; INSULIN SENSITIZING AGENT; KETOCONAZOLE; METFORMIN; ORAL CONTRACEPTIVE AGENT; ROSIGLITAZONE; SPIRONOLACTONE; TROGLITAZONE;

ADOLESCENCE; CLINICAL FEATURE; CLINICAL TRIAL; DIET THERAPY; DOSE RESPONSE; DRUG USE; ENDOCRINE DISEASE; GENOTYPE; HUMAN; HYPERANDROGENISM; HYPERINSULINISM; HYPOTHESIS; INSULIN RESISTANCE; LACTIC ACIDOSIS; METABOLIC DISORDER; ONSET AGE; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PHENOTYPE; PRIMARY PREVENTION; REVIEW; SAFETY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 3142656858     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2004.17.5.705     Document Type: Review

References (16)

1. Ibanez L, Valls C, Ferrer A, Marcos MV, Rodriguez-Hierro F, de Zegher F. Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism. J Clin Endocrinol Metab 2001; 86: 3595-3598.
2. Oberfield SE. Metabolic lessons from the study of young adolescents with PCOS-Is insulin, indeed, the culprit? [Editorial]. J Clin Endocrinol Metab 2000; 85: 3520-3525.
3. Ibanez L. Valls C, Potau N, Marcos MV, de Zegher F. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. J Clin Endocrinol Metab 2000; 85: 3526-3530.
4. Spritzer PM, Lisboa KO, Mattiello S, Lhullier F. Spironolactone as a single agent for long-term therapy of hirsute patients. Clin Endocrinol (Oxf) 2000; 52: 587-594.
5. Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A, Johnston DG, Franks S. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol 1993; 39: 351-355.
6. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, Zanolin E, Muggeo M. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000; 85: 139-146.
7. Vrbikova J, Hill M, Starka L, Vondra K. Prediction of the effect of metformin treatment in patients with polycystic ovary syndrome. Gynecol Obstet Invest 2002; 53: 100-104.
8. Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L. Metformin to restore normal menses in oligoamenorrheic teenage girls with polycystic ovary syndrome (PCOS). J Adolesc Health 2001; 29: 160-169.
9. Arslanian SA, Lewy V, Danadian K, Saad R. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab 2002; 87: 1555-1559.
10. Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 2001; 50: 1457-1461.
11. Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, O'Keefe M, Ghazzi MN, PCOS/Troglitazone Study Group. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 2001; 86: 1626-1632.
12. Kelly CJ, Gordon D. The effect of metformin on hirsutism in polycystic ovary syndrome. Eur J Endocrinol 2002, 147: 217-221.
13. Pasquali R, Antenucci D, Casimirri F, Venturoli S, Paradisi R, Fabbri R, Balestra V, Melchionda N, Barbara L. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 1989; 68: 173-179.
14. Venturoli S, Marescalchi O, Colombo FM, Macrelli S, Ravaioli B, Bagnoli A, Paradisi R, Flamigni C. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism. J Clin Endocrinol Metab 1999; 84: 1304-1310.
15. Pasquali R, Gambineri A, Anconetani B, Vicennati V, Colitta D, Caramelli E, Casimirri F, Morselli-Labate AM. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment. Clin Endocrinol (Oxf) 1999; 50: 517-527.
16. Pierpont T, McKeigue PM, Jacobs HS. Mortality of women of PCOS at long term follow up. J Clin Epidemiol 1998; 51: 581.